Home

Eli Lilly (LLY)

845.05
+0.00 (0.00%)
NYSE · Last Trade: Oct 7th, 4:25 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Dealmarketbeat.com
Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started.
Via MarketBeat · October 6, 2025
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · October 6, 2025
Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giantsmarketbeat.com
Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.
Via MarketBeat · October 6, 2025
Eli Lilly Eyes India For Manufacturing, Plans To Spend $1 Billionbenzinga.com
Eli Lilly plans over $1 billion investment in India to expand drug manufacturing, partnerships, and a new Hyderabad facility.
Via Benzinga · October 6, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · October 6, 2025
Eli Lilly Bets Big On India With $1B Investment To Boost Mounjaro, Drug Manufacturing Networkstocktwits.com
Via Stocktwits · October 6, 2025
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalystsstocktwits.com
Via Stocktwits · October 6, 2025
Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test
In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test designed for the early detection of Alzheimer's disease biomarkers. This groundbreaking innovation, widely reported between October 1st and 6th, 2025, promises to revolutionize how Alzheimer's is diagnosed, making testing [...]
Via TokenRing AI · October 6, 2025
Eli Lilly: Beyond Weight Lossfool.com
Eli Lilly is riding a big trend.
Via The Motley Fool · October 6, 2025
The Healthcare Stock Play That Could Make Millennials Richfool.com
This investment may also make baby boomers, and those from Gen X and Gen Z, rich as well.
Via The Motley Fool · October 6, 2025
2 Beaten-Down Stocks Primed for a Comebackfool.com
The market is sleeping on these stocks, but you don't have to.
Via The Motley Fool · October 5, 2025
Viking Therapeutics Stock: A Stumble Or The Setup Of The Decade?talkmarkets.com
Viking Therapeutics is not a household name yet. But this small biotech is trying to play in the biggest money game in healthcare right now: weight loss drugs. The same field where Novo Nordisk and Eli Lilly turned into giants.
Via Talk Markets · October 4, 2025
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for sustainability. This dynamic landscape is giving rise to several high-growth sectors that are not only reshaping industries but also presenting unprecedented investment opportunities.
Via MarketMinute · October 4, 2025
Navigating the Storm: Essential Strategies to Avoid 'Bag Holder' Status in Volatile Markets
The financial markets, as of October 4, 2025, continue to be characterized by a significant degree of volatility, presenting both opportunities and perilous traps for investors. In such an environment, one of the most dreaded outcomes is becoming a "bag holder" – an investor left clinging to a security that has
Via MarketMinute · October 4, 2025
Market Defies D.C. Gridlock: S&P 500 and Dow Jones Soar to Record Highs Amidst Government Shutdown
The U.S. financial markets are currently presenting a perplexing paradox. As of October 4, 2025, both the S&P 500 and Dow Jones Industrial Average (DJIA) have surged to unprecedented record highs, exhibiting remarkable resilience. This bullish momentum, however, unfolds against a backdrop of significant political turmoil: the federal
Via MarketMinute · October 4, 2025
4 Reasons to Buy Amgen Stock Right Nowfool.com
For those with a sufficiently long investment horizon, the stock looks attractive.
Via The Motley Fool · October 4, 2025
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Marketsbenzinga.com
S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech.
Via Benzinga · October 3, 2025
Danish Equities Soar as OMX Copenhagen 20 Posts Strong Gains Amidst Bullish Market Sentiment
Copenhagen's stock market demonstrated robust performance in early October 2025, with the benchmark OMX Copenhagen 20 (OMXC20) index experiencing a significant uplift. While specific daily fluctuations are common, the period saw a notable surge, including a substantial 4.2% jump on October 1st, reflecting a broader wave of investor confidence
Via MarketMinute · October 3, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · October 3, 2025
Why Shares of Eli Lilly Soared This Weekfool.com
Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs.
Via The Motley Fool · October 3, 2025
Eli Lilly And Its Competitors Pop On The Pfizer Newstalkmarkets.com
Eli Lilly and other US-based drug makers have led the market over the last few days.
Via Talk Markets · October 3, 2025
Spotlight on Eli Lilly: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · October 3, 2025
Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)benzinga.com
Via Benzinga · October 3, 2025
My 6 Top-Ranked Stocks to Buy Now in October (2025)!fool.com
This excellent list of stocks includes growth stocks, AI stocks, and dividend stocks.
Via The Motley Fool · October 3, 2025
Federal Shutdown Paralysis: Data Delays Deepen Economic Damage Fears
The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this particular standoff especially perilous is the accompanying delay in the release of critical economic data. As agencies responsible for tracking the nation's financial
Via MarketMinute · October 2, 2025